Trevor Martin’s Mammoth Biosciences aims to use CRISPR technology to democratize disease detection. Join this TechCrunch Live event to hear from Trevor Martin and Mayfield investor Ursheet Parikh on how Mammoth Biosciences positioned itself to achieve the lofty goal. Spoiler: Trevor Martin spent time putting the basics in place to ensure future success.
If you haven’t joined us before on Grip — our TCL online platform — click here to register for free and gain access to all TechCrunch Live events, including TechCrunch Live, City Spotlight, Startup Pitch Practice, Networking and other TechCrunch community events, with just one registration.
Already part of the TechCrunch Live on Grip community? Click this link to add this session to your agenda!
TechCrunch Live records weekly on Wednesdays at 11:30 a.m. PDT/2:30 p.m. EDT. Join us!